Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Leases (2022 - 2025)

Historic Current Leases for Rapid Micro Biosystems (RPID) over the last 4 years, with Q3 2025 value amounting to $1.3 million.

  • Rapid Micro Biosystems' Current Leases rose 704.11% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 704.11%. This contributed to the annual value of $1.2 million for FY2024, which is 724.38% up from last year.
  • Rapid Micro Biosystems' Current Leases amounted to $1.3 million in Q3 2025, which was up 704.11% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Current Leases ranged from a high of $1.3 million in Q3 2025 and a low of $635000.0 during Q1 2022
  • For the 4-year period, Rapid Micro Biosystems' Current Leases averaged around $995000.0, with its median value being $1.1 million (2023).
  • Its Current Leases has fluctuated over the past 5 years, first soared by 4915.91% in 2024, then skyrocketed by 699.06% in 2025.
  • Rapid Micro Biosystems' Current Leases (Quarter) stood at $766000.0 in 2022, then soared by 47.78% to $1.1 million in 2023, then rose by 7.24% to $1.2 million in 2024, then increased by 5.19% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.3 million for Q2 2025, and $1.2 million during Q1 2025.